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Abstract
Histamine regulates arousal, circadian rhythms, and thermoregulation. Activation of H3 histamine receptors expressed by
preoptic GABAergic neurons results in a decrease of their firing rate and hyperthermia. Here we report that an increase in
the A-type K
+ current in preoptic GABAergic neurons in response to activation of H3 histamine receptors results in
decreased firing rate and hyperthermia in mice. The Kv4.2 subunit is required for these actions in spite of the fact that
Kv4.22/2 preoptic GABAergic neurons display A-type currents and firing characteristics similar to those of wild-type
neurons. This electrical remodeling is achieved by robust upregulation of the expression of the Kv4.1 subunit and of a
delayed rectifier current. Dynamic clamp experiments indicate that enhancement of the A-type current by a similar amount
to that induced by histamine is sufficient to mimic its robust effect on firing rates. These data indicate a central role played
by the Kv4.2 subunit in histamine regulation of body temperature and its interaction with pERK1/2 downstream of the H3
receptor. We also reveal that this pathway provides a mechanism for selective modulation of body temperature at the
beginning of the active phase of the circadian cycle.
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Introduction
The neurons of the tuberomammillary nucleus represent the
main source of histamine in the brain. They project their axons
throughout the brain and control arousal, attention, feeding,
circadian rhythms and thermoregulation (reviewed in [1]). The
preoptic area/anterior hypothalamus (PO/AH), region which
contains thermoregulatory neurons as well as dense histaminergic
projections appears to be the main locus in which histamine affects
body temperature [2]. Recent studies have revealed that preoptic
GABAergic neurons play an important role in the control of
thermoregulatory networks that comprise also neurons of the
rostral raphe pallidus (rRPa) and dorsomedial hypothalamus
(DMH) (reviewed in [3]). We have previously reported that
histamine influences body temperature by activating H1 and H3
receptors expressed by glutamatergic and GABAergic preoptic
neurons, respectively [4].The mechanisms involved in these
alterations of firing activity are not known. We focus in this study
on histamine signaling in GABAergic neurons of the median
preoptic nucleus (MnPO) because of their critical role in several
thermoregulatory responses [5–8].
H3 subtype receptors (H3R) are present at presynaptic
terminals and have inhibitory actions on the release of various
neurotransmitters in the brain (reviewed in [9]). The signaling
pathways activated downstream of H3 receptors involve either
PKA, the extracellular regulated MAP kinase (ERK) or Ca
2+
release from intracellular stores [10–12]. Several studies have
revealed also postsynaptic inhibitory effects of H3R activation
[4,13,14] however the signaling mechanisms involved are not
known. Here we have tested the hypothesis that H3R modulation
of A-type K
+ currents (IA) mediates histamine effects on the firing
activity of preoptic GABAergic neurons and on core body
temperature (CBT).
Materials and Methods
Ethics statement
All animal work was conducted in accordance with the
Institutional Animal Care and Use Committee of the Scripps
Research Institute (approval ID #08-0129). The standards are set
forth by American Association for the Accreditation of Laboratory
Animal Care (AAALAC) standards and the regulations set forth in
the Animal Welfare Act.
Slice preparation
Coronal tissue slices containing the median preoptic nucleus
(MnPO) were prepared from C57/Bl6 or Kv4.22/2 male mice
(28–42 days old) housed in standard conditions. The Kv4.22/2
mice were a kind gift from Dr Jeanne Nerbonne (Washington
University, St. Louis). These transgenics have been generated on
the C57/Bl6 background. Acute slices containing the median
preoptic nucleus (MnPO) were prepared as described previously
[4]. The slice used in our recordings comprised the sections
located from 0.5 mm to 0.25 mm from Bregma in the mouse
brain atlas [15] and corresponded to the location of the canulla in
our in vivo experiments (see below). The in vivo injections (a volume
of 0.2 mL) were directed to the MnPO (see below), however some
spread to nearby MPA neurons is expected. Patch-clamp
recordings were made from neurons in the median preoptic
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Results from MnPO and MPA neurons were similar and therefore
were pooled. The recorded cells were referred to as ‘‘preoptic
neurons’’. The slices were prepared at 9–11 am local time during
the ‘‘subjective light period’’ and recordings were carried out up to
the end of this period i.e. 8 pm local time.
Identification of GABAergic preoptic neurons from w-t
and Kv4.22/2 mice
GABAergic neurons represent a large proportion of MnPO
neurons and are characterized by pacemaking activity and higher
firing rates (above 6–7 Hz) than those of non-GABAergic neurons
[4]. We have used this criterion for preliminary identification of
GABAergic neurons, however only neurons in which the
expression of the GABAergic marker GAD1 was subsequently
confirmed were included in this study. For that the cytoplasm of
the recorded neurons was aspirated at the end of the experiment
and stored at 280 C. The cytoplasm samples were analyzed by
RT/PCR (as described below) in batches of 6 to 10 within 5 days
after being harvested. Fig. 1D illustrates such a test in which 6 out
of 9 recorded neurons were confirmed GAD1-positive.
Dissociated preoptic neurons from slices
The MnPO was punched out of a brain slice and incubated in
Hibernate A and papain (1 mg/ml) for 10 min. After washing out
the enzyme with Hibernate –A the cells were dissociated by gentle
trituration with a fire-polished Pasteur pipette. The cell suspension
was pelleted (1000 g for 2 min) and resuspended in Neurobasal
medium and then plated on coverslips (Biocoat, BD Biosciences,
Belgium). Cells were allowed to attach to the coverslips for 2–
3 hours before recording. For immunocytochemistry cells were
kept in culture for 7–10 days to allow them to firmly attach to the
coverslips.
Whole-cell patch clamp recording
The artificial cerebrospinal fluid (aCSF) contained: 130 NaCI,
3.5 KCI, 1.25 NaH2PO4, 24 NaHCO3, 2 CaCI2, 1 MgSO4,1 0
glucose osmolarity of 300–305 mOsm, equilibrated with 95% O2
and 5% CO2 (pH 7.4). Other salts and agents were added to this
medium. In some experiments the aCSF was supplemented with
CNQX (20 mM) and picrotoxin (50 mM) to block fast synaptic
events. A K
+ pipette solution containing 130 K-gluconate, 5 KCI,
10 HEPES, 2 MgCI2, 0.5 EGTA, 2 ATP, 1 GTP (pH7.3) was used
in most experiments. Glass micropipettes were pulled with a
horizontal puller (Sutter Instruments) using Sutter borosilicate
glass capillaries with filament. The electrode resistance after back-
filling was 2–4 MV. All voltages were corrected for the liquid
junction potential (213 mV). R-a-methylhistamine was from
Tocris (Ellisville, MO), phrixotoxin 1 (PaTx1) was from Alomone
Labs (Jerusalem, Israel), while the other substances were
purchased from Sigma. The recording chamber was constantly
perfused with aCSF (2–3 mL/min). The treatments were applied
locally using a perfusion pencil system (tip diameter 100 mm,
Automate Scientific) driven by gravity.
Temperature control
The temperature of the external solution was controlled with a
TC-344B temperature controller and an inline heater (Warner
Instruments, Hamden CT) and was maintained at 36–37uC.
Data acquisition and analysis
Data was acquired with a MultiClamp 700B amplifier digitized
using a Digidata 1320A interface and the Pclamp9.2 software
package (all from Molecular Devices, Sunnyvale, CA). The
sampling rate for the continuous recordings of spontaneous
activity was 50 kHz. After establishing whole-cell configuration
the spontaneous activity of the neuron was recorded for 2–4 min
to determine its control behavior at (36–37uC). The spontaneous
firing activity of the neurons was recorded in whole-cell mode
(current clamp, I=0). The cell capacitance was determined and
compensated using the Multiclamp Commander software. The
spontaneous firing rates (averaged over 10 s) as well as the K
+
currents were very stable over ,30 min recordings in control
extracellular solution displaying spontaneous changes of less than
63%. Therefore all changes larger than 63% in response to a
pharmacological treatment were considered ‘‘responses’’. Action
potential parameters were determined using Mini Analysis
software in which the threshold was defined as the point in which
dV/dt exceeds 4 Vs
21. The amplitude of the afterhyperpolariza-
tion (AHP) was measured as the difference between spike threshold
and the most negative voltage reached during AHP. The slope of
decay of the AHP was measured as the voltage change over 5 ms
following the most negative voltage reached.
Dynamic clamp
The dynamic clamp functionality of the QUB software (http://
www.qub.buffallo.edu/milescu) developed by Dr Lorin Milescu
[16] was run on Dell T7400 computer equipped with a Intel Xeon
quadcore processor. A National Instruments PCI 6251 card was
used for data acquisition and for generating the dynamic clamp
current. The sampling rate was 50 kHz. The real time
performance of the dynamic clamp system was adequate, with
only 1 in 10
5 cycles lasting more than 20.1 ms. IA was modeled
using the Hodgkin and Huxley formalism IA=g Am
4h(V2Vrev).
Where m and h are the occupancy probabilities for the activation
and inactivation particles, respectively. dm/dt=am*( 1 2m)2
bm*m and dh/dt=ah*(12m)2bh*h. The gating transitions are
described by the rate constants that have Eyring voltage-
dependencies: a=a0*exp a1*(V2a0.5), b=b0*exp b1*(V2b0.5)
[16]. Starting from values determined for other recordings (http://
www.qub.buffallo.edu/milescu) we have empirically determined
values that fit our recorded IA currents. The respective parameters
were: a
m
0=9, a
m
1=0.059, a
m
0.5=0, b
m
0=0.01, b
m
1=20.1,
b
m
0.5=210, a
h
0=0.001, a
h
1=20.1, a
h
0.5=225, b
h
0=0.3,
b
h
0.5=0. b
h
1 was changed among neurons to account for the
differences in inactivation rate and ranged from 0.10 to 0.15. We
have tested our models online using a model cell (Patch-1U,
Molecular Devices) attached to the second stage of the Multiclamp
700B: step depolarizations from a holding potential of 2110 mV
were applied and the currents elicited by the dynamic clamp
where compared with those recorded in the modeled neuron. The
two traces were compared using a minimum sum of squared
errors.
Immunocytochemistry and confocal imaging
Coverslips were washed by immersion in HBS, fixed in ice-cold
4% paraformaldehyde for 30 min, and then incubated for 10 min
at room temperature in PBS containing 0.25% Triton X-100.
Nonspecific sites were blocked by incubation in PBS containing
10% normal goat/horse serum. Antibodies against Kv4.2 and
Kv4.3 were from Neuromab (UC Davis), the Kv4.1 antibody was
from Alomone Labs (Jerusalem, Israel), the H3 and the GAD67
antibodies were from Invitrogen (Temecula, CA). The specificity
of the antibodies was checked by the supplier and by previous
studies by others. We have confirmed the specificity of the Kv4.2
antibody by staining Kv4.22/2 neurons. Specific binding was
detected by using secondary antibodies conjugated to AlexaFluor
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collected on a Delta Vision Optical Sectioning Microscope
(Olympus, Melville, NY). Multiple consecutive optical sections at
a 0.24 mm interval were acquired for each of the fluorescent
probes by using a 606oil objective. The settings of the confocal
were kept constant so that the images could be analyzed by
densitometry and the different conditions could be compared. 15
different fields in each coverslip were captured, and all neurons in
the pictures were analyzed for their green and red fluorescence
content. Backgrounds were defined as the fluorescence intensity in
non-neuronal fields and subtracted from the values obtained for
each neuron. Using Image J software (NIH) we have quantified the
intensity of the fluorescent signal as integrated density.
Cell harvesting and reverse transcription
Preoptic neurons in slices or dissociated were patch-clamped
and then harvested into the patch pipette by applying negative
pressure. The content of the pipette was expelled in a PCR tube.
dNTPs (0.5 mM), 50 ng random primers (Invitrogen) and H2O
were added to each cell to a volume of 16 ml. The samples were
incubated at 65uC for 5 min and then put on ice for 3 min. First
strand buffer (Invitrogen), DTT (5 mM, Invitrogen), RNaseOUT
(40 U, Invitrogen) and SuperScriptIII (200 U, Invitrogen) were
added to each sample to a volume of 20 ml followed by incubation
at room temperature for 5 min, at 50uC for 50 min and then at
75uC for 15 min. After reverse transcription samples were
immediately put on ice. 1 ml of RNAse H was added to samples
and kept at 37uC for 20 min.
Nested PCR
Gene specific primers for GAD1 and histamine receptor H3
were as described elsewhere [4]. cDNAs were amplified in a
volume of 25 ml using a high-fidelity Platinum Taq polymerase kit
(Invitrogen) and 0.4 mM dNTPs (Invitrogen). For each gene 1/10
of the cDNA from each cell was subjected to a first round of PCR
using the outer primer pair and a thermal cycling program with an
initial denaturation at 94uC for 2 min, 35 cycles of denaturation at
94uC for 15 s, annealing at 55uC for 30 s and extension at 68uC
for 45 s followed by a final extension at 68uC for 10 min. 1.5 mlo f
the PCR product was subjected to a second round of PCR using
the inner primer pair and 40 cycles of the same thermal cycling
program as above with the extension time reduced to 30 s. PCR
products were visualized by ethidium bromide stained 2% agarose
gel electrophoresis.
RT/QPCR
Preoptic tissue obtained from slices was stored at 280 degree
Celsius until the time of RNA extraction. Total RNA was
extracted using Qiagen RNAeasy kit manufacturer’s instructions.
RNA extraction was conducted in dry ice. The concentration of
RNA was determined using a nanodrop measuring the absorbance
at 260 nm with reference to 280 nm. RNA was then stored at 280
degree Celsius. 4 mg RNA was then reverse-transcribed into first-
complimentary DNA (cDNA) using Superscript III reverse
transcriptase kit (Invitrogen, CA) according to manufacturer’s
instructions. The reaction was inactivated by incubating it at 75uC
for 10 minutes. In order to remove RNA complimentary 1 ml
RNAse H was added to the reaction and was incubated at 37uC
for 20 minutes. The concentration of prepared cDNA was
measured using nanodrop measuring absorbance at 230 nm with
reference to 280 nm. Quantitative PCR reactions were performed
in duplicate using Roche light-cycler and the following parameters
were used for 45 cycles (95uC for 10 minutes, 95uC for 5 seconds,
60uC for 5 seconds, 72uC for 8 seconds for 45 cycles; for melting:
95uC for 5 seconds, 65uC for 5 seconds; for cooling 40uC for 30
seconds). Each 20 ml of PCR reaction contained: 4 ml Sybr green
(Roche, enzyme mixed according to manufacturer’s instructions),
9 ml PCR graded water, 2 ml1mM gene of interest primer and
5 ml diluted cDNA (1/30 dilution). Each reaction included a
standard curve. To determine a standard curve, 1 ml of the non-
diluted cDNA for all samples were mixed and a dilution of 1:100,
1:50 and 1: 25 was made. The standard curve is used for
determining the efficiency of the primer and calculating the
concentration of the mRNA amplified in the QPCR reaction. The
concentration of each gene was normalized using the housekeep-
ing gene GAPDH. Primers used were: Kv4.1 (NM_008423) sense
59-GCTGCTCTCGAAGGGTCAAT-39, antisense 59-CACGG-
CTGACAGAGGCAGTA-39, Kv4.3 (NM_001039347) sense 59-
CCTGCTGCTCCCGTCGTA-39, antisense 59- GGGTGGCA-
GGCAGGTTAGA-39.
Radiotelemetrv studies of core body temperature and
motor activity
Mice were implanted with the radio transmitter (TA10TA-
F20
TM and RPC-1
TM, Data Sciences, Inc.) as previously described
[4]. The cages were positioned onto the receiver plates. Radio
signals from the animals’ core body temperature (CBT) and motor
activity (MA) were continuously monitored by a fully automated
data acquisition system (Dataquest
TM A.R.T.
TM, Data Sciences,
Inc). C57/Bl6 and Kv4.22/2 adult males (12–14 weeks old) were
used for the in vivo experiments.
Stereotaxic injections
Cannula implantation and injections were carried out as
previously described [4]. Coordinates for cannula (27 ga. 16 mm
length) implants in the median preoptic nucleus (MnPO): from
Bregma: 0.38 mm and ventral 4.6 mm [15]. The ambient
temperature was maintained at ,2560.5uC in a 12:12-h lightdark
cycle controlled room (lights on 8:00 am). H3R ligands and the
MEK-1 inhibitor PD98059 were injected into the MnPO. All
substances injected were dissolved in sterile aCSF. Mice were
handled for at least three days before the injection during
5 minutes every day for habituation. On the day of injections,
Figure 1. H3R activation increases IA in preoptic GABAergic neurons. (i) Voltage-gated K
+ currents recorded in the presence of TTX in
control (left) and after 4 min incubation with R-a-methylhistamine (1 mM) (right). The currents were elicited by the voltage step protocol depicted in
the inset. (ii) IDR elicited by the voltage step protocol depicted in the inset before (left) and during R-a-methylhistamine (1 mM) incubation (right). (i–
ii) Separation of IA by subtraction of IDR from the total voltage-gated K
+ current. Note the increase in IA amplitude during R-a-methylhistamine (1 mM)
incubation (right). B. Voltage dependence of the normalized peak IA amplitude in control (N), during H3 agonist incubation (#), and of their ratios
(&). Control currents were normalized relative to the value at 0 mV. The peak currents during H3 agonist incubation were normalized to the
respective control. Pooled data from 6 neurons presented as means 6 S.D. C. K
+ current elicited by a depolarizing step to 220 mV in control (left),
during PaTx1 (600 nM) incubation (middle) and the PaTX1 sensitive component obtained by subtraction (right). D. Agarose gels illustrating the
expression of GAD1 (left) and H3R (right) in a batch of nine (1–9) recorded preoptic neurons. The expected sizes of the PCR products are (in base
pairs) 244 and 403, respectively. Negative (2) control was amplified from a harvested cell without reverse-transcription, and positive control (+) was
amplified using 1 ng of hypothalamic mRNA.
doi:10.1371/journal.pone.0029134.g001
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was placed inside the cannula. The injector was connected to a
microsyringe (1.0 mL). The injected volume was 0.2 mL (rate
0.1 mL/min). After this procedure the animal was returned to the
home cage. Injections were always performed at 12 am local time,
during the ‘‘subjective light period’’.
Histology
The cannula placement was always checked at the end of the
experiments by blue pontamine dye injection. The animals were
then killed and the brains were removed and cryosectioned. The
cannula placement in the MnPO was confirmed using an inverted
microscope.
Figure 2. Activation of H3 subtype histamine receptors reduces the firing rate of preoptic w-t GABAergic neurons but has no effect
on the firing rate of Kv4.22/2 neurons. A. Single channel confocal images showing immunoreactivity to Kv4.2 (Left, green) and Kv4.3 (Middle,
red) and their superimposition (Right, merge) obtained from dissociated w-t preoptic neurons. B. Immunoreactivity to H3R (Left, green) and GAD1
(Middle, red) and their superimposition (Right, merge) obtained from dissociated Kv4.22/2 preoptic neurons. Note the immunoreactivity to both H3R
and GAD1 of a Kv4.22/2 neuron. C, D. Expanded fragments of a recording showing ‘‘pacemaker’’ firing of the neuron in control (upper trace), during
R-a-methylhistamine (1 mM) application (middle), and during washout (lower) from a w-t (C) and a Kv4.22/2 (D) dissociated neuron. E. Average firing
rate (for every 10 s) recorded before, during, and after application of R-a-methylhistamine (1 mM). The filled circles (N) and squares (%) correspond to
the experiment presented in B and C, respectively.
doi:10.1371/journal.pone.0029134.g002
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The values reported are presented as mean 6 standard
deviation (S.D.). Statistical significance of the results pooled from
two groups was assessed with t-tests using Prism4 (GraphPad
Software). Non-parametric one way analysis of variance (ANOVA,
Kruskal-Wallis) with Dunn’s post hoc test (P,0.05) was used for
comparison of multiple groups. Comparisons of cumulative
distributions were done with Kolmogorov-Smirnov test
(P,0.05). All data collected as time series were compared across
genotypes and time points by two way ANOVA with repeated
measures (P,0.05), followed by unpaired t-tests (P,0.05) for
comparisons at each time point (Prism4, GraphPad Software).
Results
Activation of H3R receptors increases the A-type K
+
current in preoptic GABAergic neurons
We have previously reported that activation of H3R histamine
receptors results in a potent decrease in the firing rate of preoptic
GABAergic neurons, effect that was not dependent on synaptic
activity or changes of resting membrane potential [4]. We
hypothesized that the agonist modulates the ‘‘pacemaking’’
mechanism. Therefore we tested the effect of the H3 agonist R-
a-methylhistamine (1 mM) on voltage-gated conductances that are
involved in rhythmic firing activity and have been identified in
preoptic neurons: Na
+ current, A-type K
+ current (IA), delayed
rectifier K
+ current (IDR), L-type and T-type Ca
2+ currents, and Ih
current [17,18]. GABAergic neurons were identified as described
in Materials and Methods. IA increased during incubation with the
H3 agonist (Fig. 1A) in a population of GABAergic neurons while
the other currents were not affected. The IA was isolated by a
voltage step protocol: the neuron was depolarized from a holding
potential of 260 mV to test potentials between (260 and +10)
with or without a conditioning step to 2110 mV. Without the
conditioning step (that allows IA to recover from inactivation) the
elicited currents had no distinguishable transient component. By
subtracting them from the currents obtained with the conditioning
pulse we could separate IA, however a small IDR was still present
(Fig. 1A). To fully separate IA we have added TEA (5 mM) and 4-
AP (0.25 mM) (see below) to the extracellular solution. After
measuring IA twice in control conditions to verify its stability, we
bath applied R-a-methylhistamine (1 mM) and within 3 minutes
we noticed an increase in the current’s amplitude (Fig. 1A). In
contrast IDR was not modified by the agonist. Similar results were
obtained in 5 other GABAergic neurons out of 18 tested, reflecting
the percentage of H3R expressing cells [4]. The increase in IA
amplitude averaged 1864% (n=6 out of 18, P,0.05, paired t-test
relative to control amplitudes) at 220 mV test potential. The
enhancement of IA peak currents in the presence of the agonist was
statistically significant (t-test, P,0.05) and of similar size at all
voltages tested (Fig. 1B). In the remaining 12 neurons the agonist
had no effect on either IA or IDR.
To allow a faster exchange of extracellular solutions and to
avoid space clamp limitations as well as possible presynaptic effects
activated by pharmacological treatments we continued this study
on acutely dissociated preoptic neurons from slices (see Methods).
As observed in slices, R-a-methylhistamine (1 mM) induced an
enhancement of IA in a subpopulation of GABAergic neurons that
averaged 1865% (n=10, out of 29 neurons studied) at 220 mV
test potential. The percentage increase values were similar to those
observed in neurons recorded in slices (p.0.5, t-test). The agonist
was without effect on either IA or IDR in the remaining GABAergic
neurons. To verify that the effect was due to activation of H3Rs we
have tested the agonist after incubation with the H3R antagonist
thioperamide (1 mM). In the presence of the antagonist, R-a-
methylhistamine (1 mM) was without effect in all GABAergic
neurons tested (n=26). Finally, we have probed the expression of
the H3R transcripts using single cell RT/PCR in cells in which R-
a-methylhistamine (1 mM) effects on IA were tested. In 4 out of 4
neurons in which the agonist increased IA we have detected H3R
transcripts. Conversely, H3R transcripts were not detected in any
of the 21 neurons where the agonist had no effect. Fig. 1D
illustrates such an analysis of a batch of 9 recorded neurons: 6
were GAD1-positive two neurons in which IA was enhanced by the
H3 agonist were found to be also H3R-positive, while the
remaining neurons were H3R-negative.
Several subunits belonging to the Kv1, 3 and 4 families can
form channels that conduct IA currents. To identify the Kv
subunits that contribute to IA in preoptic GABAergic neurons we
have first carried out pharmacological experiments. IA was very
sensitive to the Kv4-selective phrixotoxin-1 (PaTx-1)(600 nM).
The amplitude of the current (at 220 mV test potential) reversibly
decreased by 76611% (n=5, P,0.01 paired t-test relative to
control amplitudes) in the presence of the toxin (Fig. 1 C). The
toxin displayed similar potency at all voltages tested (230 to
0 mV).
Effects of H3R agonist on the spontaneous activity of w-t
and Kv4.22/2 GABAergic preoptic neurons
Kv4.2 and Kv4.3 subunits are highly expressed in many regions
of the brain, including in the hypothalamus, in contrast to Kv4.1
subunits that are present only at low levels. Immunocytochemistry
experiments on preoptic neurons revealed co-expression of Kv4.2
and Kv4.3 subunits in most neurons (Fig. 2A). In comparison
Kv4.1 subunits were expressed only at low levels in preoptic
neurons (see below). Since Kv4.2 is a pERK substrate [19] we
tested the hypothesis that it plays a role in modulating the firing
activity and IA of preoptic neurons downstream of H3R. Thus we
compared the effect of H3 agonist in acutely dissociated w-t and
Kv4.22/2 preoptic neurons. The spontaneous pacemaking
activity and responses to H3 agonist of dissociated w-t preoptic
neurons were very similar with those recorded in w-t slices (4). The
average firing rate of a subpopulation of w-t neurons was inhibited
by 4867% (n=6 out of 14 GABAergic neurons tested) during R-
a-methylhistamine (1 mM) incubation (Fig. 2 B), value similar with
Table 1. Properties of preoptic GABAergic w-t and Kv4.22/2
neurons.
Parameter w-t n Kv4.22/2 n
r.m.p. (mV) 252.364.4 14 250.665.1* 15
Rinput (MV)4 0 7 662 14 427653 15
S. f. r. (Hz) 10.263.7 14 9.463.5 15
AP amplitude (mV) 77.264.4 14 78.365.7 15
AP threshold (mV) 243631 4 244641 5
AP halfwidth (mV) 0.860.1 14 0.960.1 15
AHP amplitude (mV) 217.863.1 14 219.263.2 15
AHP time to peak (ms) 5.563.4 14 4.963.9 15
AHP decay (mV/ms) 0.2360.22 14 0.2560.2 15
Peak IA density at 0 mV (pA/pF) 58.6619.5 14 41.8612.9* 15
ISS density at 0 mV (pA/pF) 45.4619.5 14 82.3627.5** 15
Values are presented as mean 6 S.D., * and ** indicate P,0.05 and P,0.01,
respectively (unpaired t-tests), (n)-number of cells.
doi:10.1371/journal.pone.0029134.t001
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Kv4.22/2 GABAergic neurons displayed spontaneous pacemak-
er activity and action potential parameters similar with those of w-t
cells (Table 1). The resting membrane potential (measured in
TTX) was slightly more depolarized in Kv4.22/2 cells (Table 1).
A striking difference was that Kv4.22/2 GABAergic neurons
displayed only very small responses to the H3 agonist (Fig. 3 C,D).
The average firing rate decreased by 165% (n=6 of 23 neurons
studied). R-a-methylhistamine (1 mM) increased the firing rate in
two Kv4.22/2 GABAergic neurons and decreased it in the others
(n=4). In the remaining 17 neurons the agonist was without effect.
The percent reduction of firing rates was significantly lower in
Kv4.22/2 neurons than in w-t neurons (unpaired t-test, P,0.05).
To address this discrepancy we investigated the expression of H3R
Figure 3. Voltage-gated K
+ currents recorded in w-t and Kv4.22/2 preoptic GABAergic neurons. A. Voltage-gatedK
+currents recorded in
the presence of TTX(1 mM) in w-t (left)andKv4.22/2 (right) neurons. Thecurrents were elicited by the voltage step protocol depicted in the inset. Note
the large IDR present in the Kv4.22/2 neuron. B. Separation of IA in the presence of TEA and 4-AP. The currents were elicited by the same voltage step
protocol as in A.Recordings were fromthesame neurons as in A (upper traces). Lower traces representthe sametracesonanexpandedtimescale.C. I–V
plot forpeak IA amplitudein w-t(N) andKv4.22/2 neurons (%) recordedin the presenceof TEA and4-AP. D. I–Vplot forthesteadystatecomponentof
the current at the end of the depolarizing steps (Iss) in w-t (N) and Kv4.22/2 neurons (%) recorded in standard extracellular solution. C, D. Data points
representaverages 6S.D. from n=14 w-t neurons andn=15 Kv4.22/2 neurons. Thedata points at 270, +10 and+20 mVarefrom a subset of n=6 w-t
neurons and n=6 Kv4.22/2 neurons. E. IA currents recorded in the presence of TEA and 4-AP in response to the voltage step protocol depicted in the
inset. A depolarizing step to 0 mV was preceded by a 200 ms conditioning step to voltages ranging from 2130 to 230 mV. F. Voltage-dependence of
inactivation of IA recorded in w-t (N, n=8) and Kv4.22/2 neurons (%, n=8). Data presented as averages 6 S.D.
doi:10.1371/journal.pone.0029134.g003
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RT/PCR. GAD1 and H3R immunoreactivities colocalized in
,50% of neurons studied (n=64 out of 131) (Fig. 2B). As
previously found in w-t neurons [4] H3R transcripts were detected
in a subpopulation (5 out of 13 GAD1 positive neurons, i.e. 38%)
of GABAergic neurons. We have also quantified the concentration
of H3R transcripts in w-t and Kv4.22/2 mRNA extracted from
preoptic tissue (n=6 mice each). No difference in H3R transcript
concentration (normalized to GAPDH) was observed between w-t
and Kv4.22/2 RNA samples (P.0.2, t-test) (data not shown).
We therefore hypothesized that the lack of sensitivity to H3R
agonist of Kv4.22/2 neurons is due to differences in IA or in their
sensitivity to modulation by H3R activation.
A marked difference of voltage-gated K
+ currents recorded in
Kv4.22/2 GABAergic neurons was that the IDR had larger
amplitude than in w-t GABAergic neurons (Fig. 3A, D). We then
tested the K
+ current sensitivity to 4-AP (0.25 mM) and TEA
(5 mM), blockers for Kv1 and Kv3 subunit families, respectively.
We found that only the IDR component was sensitive to either
blocker in w-t and Kv4.22/2 GABAergic neurons. Combining
the two blockers provided us with an effective means of separating
IA from the IDR (Fig. 3A). Surprisingly, the IA current density (peak
amplitude/cell capacitance) was only 14% smaller in the
transgenic (P,0.05, t-test, n=14 and n=15 w-t and Kv4.22/
2 neurons, respectively). The voltage–dependence of activation
(Fig. 3C, D) and inactivation (-Fig. 3E, F) were similar in w-t and
Kv4.22/2 GABAergic neurons. The IDR density was 81% larger
(P,0.01 unpaired t-test, n=14 and n=15 w-t and Kv4.22/2
neurons, respectively) in Kv4.22/2 neurons (Fig. 3A, D).
We have also compared several electrical characteristics
(membrane potential, firing rate, action potential characteristics,
IA current density, etc) of w-t GABAergic neurons in which IA was
potentiated by the H3 agonist (n=6) with those of a group of w-t
GABAergic neurons in which the current was not changed (n=8).
No differences were found between the two groups (P.0.1, t-tests)
and therefore the data were pooled (Table 1).
Activation of H3R specifically modulates IA conducted by
Kv4.2-containing channels
Since IA properties were little changed in Kv4.22/2 neurons
we then questioned whether the lack of effect of the H3 agonist on
the spontaneous firing activity of preoptic GABAergic neurons was
due to a lack of effect on the IA amplitude, or to other
compensatory mechanisms. A decrease in the level of pERK1/2
mimics the effects of H3R activation [4] on the firing activity of
preoptic neurons therefore we also studied the effects of the MEK-
1 inhibitor PD98059 (10 mM) on the IA properties. As described
above, R-a-methylhistamine (1 mM) increased IA in 35% of w-t
GABAergic neurons studied by 1865% (n=10 out of 29). In
Figure 4. Effects H3 agonist on IA in w-t and Kv4.22/2 GABAergic preoptic neurons. A,B. IA recorded from a w-t neuron (A)anda Kv4.22/2
neuron (C) in control (left), after 5 min incubation with R-a-methylhistamine (1 mM) (middle) andafter washout of the agonist (right). B. IA recorded from
a w-t neuron in control (left), after 5 min incubation with PD98059 (10 mM) (middle) and after subsequent 5 min incubation with R-a-methylhistamine
(1 mM) (right). A–D. The currents were elicited by the voltage steps to 240, 230 and 220 mV from a holding potential of 2110 mV. The extracellular
solution contained TTX (1 mM), TEA (5 mM) and 4-AP (0.25 mM). E. Bar chart of the percentage increase in the peak IA amplitude (at 220 mV) test
potentialbyR-a-methylhistamine(1 mm).**indicatesstatisticalsignificanceofP,0.01when comparedwiththeother3 columns (ANOVA, Kruskal-Wallis
with Dunn’s post test). The bars represent averages 6S.D.
doi:10.1371/journal.pone.0029134.g004
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29134Figure 5. Lack of effect of H3 agonist on IA kinetics in GABAergic preoptic neurons. A,B. IA recorded from two w-t neuron in control (left),
after 5 min incubation with R-a-methylhistamine (1 mM) (middle) and their scaled overlap (right). The currents were elicited by the voltage steps to
0 mV from a holding potential of 2110 mV. The extracellular solution contained TTX (1 mM), TEA (5 mM) and 4-AP (0.25 mM). The traces in A were
fitted by a single exponential decay A*e(2t/t). T was 10.3 ms in the control and 10.6 during H3 agonist incubation. The currents in B were fitted with
a biexponential decay A1*e(2t/t1)+A2*e(2t/t2). T1 was 2.9 ms in the control and 3.0 ms during H3 agonist incubation. T2 was 29.4 ms in the control
and 28.9 ms during H3 agonist incubation. C. Voltage-dependence of the time constants of IA decay. Some cells displayed monoexponential decay (t)
(n=6) or biexponential decay (t1 and t2) (n=4) in control (black) and during H3 agonist incubation (white). The data points at +10 and +20 mV are
from 4 neurons dispaying monoexponential decay. D. Voltage-dependence of the A2/A1 ratio of neurons that displayed biexponential decays (n=4)
in control (N), and during H3 agonist incubation (#). E. Voltage-dependence of the time to peak of IA (n=10) in control (N), and during H3 agonist
incubation (#). C–E. Data are presented as averages 6 S.D.
doi:10.1371/journal.pone.0029134.g005
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PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29134Figure 6. Upregulation of the level of expression of Kv4.1 subunits in Kv4.22/2 preoptic neurons. A. Single channel confocal images
showing immunoreactivity to Kv4.1 (Left, green) and Kv4.2 (Middle, red) and their superimposition (Right, merge) obtained from dissociated w-t
(upper row) and Kv4.22/2 (lower row) preoptic neurons. B. Cumulative histograms of the Kv4.1 staining intensity in w-t (blue circles, n=708
neurons) and Kv4.22/2 neurons (red triangles, n=811 neurons). The distributions were significantly different (P,0.01, Kolmogorov-Smirnov test). C.
qPCR analysis of Kv4.1 (left) and Kv4.3 gene (right) expression in preoptic area from w-t and Kv4.22/2 mice (n=6 mice each). For normalization
GAPDH was selected as housekeeping gene. Bars represent averaged normalized concentrations 6 SD. ** represents significant differences between
w-t and Kv4.22/2 groups P,0.01 (t-test).
doi:10.1371/journal.pone.0029134.g006
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Kv4.22/2 GABAergic neurons at 220 mV test potential (Fig. 3
A,C,D). R-a-methylhistamine (1 mM) decreased IA in two
Kv4.22/2 GABAergic neurons and increased the current in
the others (n=6). PD98059 (10 mM) mimicked the action of the
H3 agonist in w-t neurons: it increased IA by 2066% (n=5 out of
7) (Fig. 4 B, D). The H3 agonist did not have any effect on the IA
amplitude in neurons pretreated with PD98059 (Fig. 4 B, D). We
also tested for possible effects of H3R activation on the IDR in
Kv4.22/2 neurons. As described above for w-t neurons, R-a-
methylhistamine (1 mM) was without effect on IDR (n=12).
We have also studied possible effects on IA kinetics in neurons in
which the current was enhanced by the H3 agonist. IA decay was
fitted by a single exponential decay in 6 out of 10 neurons studied
Figure 7. Dynamic clamp experiments reveal the role of IA in the pacemaking activity of preoptic neurons. A. Comparison between the
recorded IA (black) and those generated by the corresponding model (red). The currents were elicited by step depolarizations from 2110 mV holding
potential to the indicated test potentials. B. Spontaneous firing activity in a preoptic neuron in control (left upper trace) and when the IA current is
increased by 10% (middle upper trace) or 20% (right upper trace). The lower traces represent the IA injected by the dynamic clamp. Note the
prolonged ramp-like potentials that precede a spike and the presence of subthreshold membrane potential oscillations (*) during dynamic clamp. C.
Voltage-dependence of activation (N) and inactivation (m)o fI A recorded from w-t neurons (data replotted from Fig. 3 C and F). The lines represent
voltage-dependence of activation (dashed line) and inactivation (dotted line) of IA generated by our model.
doi:10.1371/journal.pone.0029134.g007
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decay (Fig. 5B). The H3 agonist did not change the time constants
of the exponential decays in any of the 10 neurons (Fig. 5A–C).
The agonist also did not change the relative weights of the fast and
slow components in bi-exponential decays (Fig. 5D). Finally, the
H3 agonist did not change the time to peak in any neuron (n=10,
Fig. 5E).
Molecular identity of the K
+ channels conducting IA in
Kv4.22/2 GABAergic preoptic neurons
IA was insensitive to 4-AP and TEA in w-t and Kv4.22/2
GABAergic preoptic neurons while IDR was fully blocked by the
combined blockers (Fig. 3A,B). We then studied the effect of
PaTX1 (600 nM) on the IA of Kv4.22/2 GABAergic neurons.
The blocker reduced IA by 70613% (n=5), value similar with that
observed for w-t GABAergic neurons (P.0.5, unpaired t-tests).
These results indicated the involvement of Kv4.1 and/or Kv4.3
subunits in the generation of IA in Kv4.22/2 neurons.
To clarify the expression of the Kv4 subunits we have
performed immunocytochemistry experiments on w-t and
Kv4.22/2 preoptic neurons. Kv4.2 and Kv4.3 were highly
expressed in w-t neurons (Fig. 2A) while Kv4.1 was expressed at
low levels (Fig. 6A). In contrast, the transgenic preoptic neurons
the level of expression of Kv4.1 was high (Fig. 6A, B) while Kv4.3
expression levels remained the same. We have also carried out
qPCR on RNA extracted from preoptic tissue from w-t and
Kv4.22/2 mice (n=6 mice each). After reverse transcription of
RNA was performed, Kv4.1, Kv4.3 and GAPDH expression was
measured using qPCR (Fig. 6C). When normalized with respect to
GAPDH gene expression, levels of Kv4.1 were found to be ,3
fold increased in the Kv4.22/2 samples when compared to the
wild-type samples (t-test, P,0.01). In contrast, the levels for Kv4.3
transcripts appeared to decrease albeit the difference was not
statistically significant (t-test, P.0.2) (Fig. 6C).
Dynamic clamp simulation of an increase in IA in w-t and
Kv4.22/2 neurons
In order to determine whether an increase in IA could account
for the decrease in the spontaneous firing activity of dissociated
preoptic neurons we carried out dynamic clamp experiments. We
have first measured IA in a neuron as described above (in the
presence of TTX, 4-AP and TEA) and then washed out the drugs
to recover the spontaneous firing activity. Meanwhile we have
determined the Hodgkin-Huxley model that fitted the currents (see
Methods) (Fig. 7A). Using dynamic clamp we have added an IA
component with a maximum conductance of 10% or 20% of gKa
(according to the model calculated for the same cell). Increasing IA
by 10% and 20% resulted in a decrease of the average firing rate
by 19% and 52%, respectively (Fig. 7B). The ramp-like potentials
preceding the action potentials were prolonged during dynamic
clamp. We have also noticed sub-threshold oscillations in the
membrane potential during dynamic clamp (* in Fig. 7B). Results
Figure 8. Responses to intra-MnPO injection of H3R agonist and sulprostone in w-t and Kv4.22/2 mice. A. Intra-MnPO injection of H3R
agonist (10 mM, 0.2 ml) induced hyperthermia (upper panel) and did not affect motor activity (MA)(lower panel) in w-t and Kv4.22/2 mice (red and
black traces, respectively). The CBT response was significantly smaller in Kv4.22/2 mice (two-way repeated measures ANOVA, followed by t-tests for
each time point, * P,0.05). B. Intra-MnPO injection of EP1/3 agonist sulprostone (10 mM, 0.2 mL) induced hyperthermia (upper panel) and did not
affect motor activity (MA)(lower panel) in w-t and Kv4.22/2 mice. The responses were not different in the w-t and Kv4.22/2 mice (P.0.4 two-way
repeated measures ANOVA). C. Intra-MnPO injection of PaTx1(800 nM, 0.2 mL) or PaTx1+H3 agonist (800 nM and 10 mM, 0.2 mL) induced a slight
hyperthermia of 0.4 and 0.6uC, respectively, (upper panel) and did not affect motor activity (MA)(lower panel) in w-t and Kv4.22/2 mice. The
responses were not different (P.0.2 two-way repeated measures ANOVA). A–C. The line graphs represent averages6S.D. (n=6 mice) through the
10 h recording period. Experiments were carried out in parallel in 2 groups of 6 mice for each treatment.
doi:10.1371/journal.pone.0029134.g008
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1865% (n=6) and 4665% (n=6) when IA was augmented by 10
and 20%, respectively. Since the Kv4.22/2 preoptic neurons
presented electrical remodeling, i.e. smaller IA and much larger
IDR (see above), we then questioned whether their firing rates
would be influenced by an increase in IA. Results in 5 Kv4.22/2
neurons studied were similar to those in w-t neurons: a decrease of
2064% (n=4, P.0.5, unpaired t-test) and 4967% (n=4, P.0.5,
unpaired t-test) when IA current was augmented by 10 and 20%,
respectively.
Effects of intra-MnPO injection H3R agonist on core body
temperature and motor activity in w-t and Kv4.22/2 mice
We have previously reported that histamine and the H3 agonist
R-a-methylhistamine injected in the MnPO increase core body
temperature (CBT) without changing motor activity (MA) [4].
Here we compared the effect of the H3 agonist (10 mM, 0.2 mL) in
w-t and Kv4.22/2 mice. Experiments were carried out in parallel
in 2 groups of 6 mice. The agonist induced a robust hyperthermia
when injected in the MnPO (Fig. 8A, upper panel), an effect which
was not accompanied by increased motor activity (Fig. 8A, lower
panel), suggesting that it was due to changes in thermoregulation
(e.g. brown adipose tissue thermogenesis). In contrast, the
Kv4.22/2 mice developed a much smaller hyperthermia (two-
way repeated measures ANOVA, P,0.01). Control aCSF
injections (0.2 mL, control) did not result in hyperthermia in
either strain of animals (Fig. 9A). As a positive control, we have
also tested the ability of Kv4.22/2 mice to develop thermogenic
responses by injecting a potent pyrogen, the EP1/3 prostanoid
receptor agonist sulprostone (5 mM, 0.2 mL). The responses of
Kv4.22/2 mice were indistinguishable from those of w-t mice
(Figure 7B) and reached a maximum value of ,2uC above
baseline, proving that these transgenics are able of developing a
full amplitude hyperthermia. We have tested then the effect of the
H3 agonist when co-applied with PaTx1 (10 mM and 800 nM,
respectively, in 0.2 mL final volume). In the presence of the toxin
the effect of the agonist was abolished (Figure 8C), i.e. the
responses to PaTx1 (800 nM, 0.2 mL) and PaTx1+ H3 agonist
were not different (two-way repeated measures ANOVA, P.0.1).
Histamine has been reported to be a potent modulator of circadian
rhythms in vivo and in vitro (reviewed in [1]). We have first examined the
circadian pattern in CBT and MA in w-t and Kv4.22/2 mice. The
only difference observed was that in the transgenic the rise in CBT
associated with the onset of the dark phase of the cycle was delayed by
,1 h (* in Fig. 9A). Similar observations were made in 2 other sets of
w-t and Kv4.22/2 mice (n=6 each). Therefore, to determine
whether the circadian rhythm in CBT is influenced by preoptic
histamine signaling, we have injected the H3 antagonist thioperamide
(1 mM, 0.2 mL, n=6 each) intra-MnPO in w-t and Kv4.22/2 mice.
The antagonist delayed the rise in CBT by ,1 h in w-t mice but was
withouteffect inthe transgenic (Fig.9B), i.e.afterthioperamide infusion
the CBT profiles of the w-t and Kv4.22/2 mice were overlapping. In
contrast, the antagonist had no effect on the MA of the mice (two-way
repeated measures ANOVA, P.0.4). We then studied the role of Kv4
subunits expressed by preoptic neurons in the circadian CBT profile by
Figure 9. Circadian CBT and MA profiles and responses to H3 antagonist infusions. A. Intra-MnPO injection of aCSF (0.2 mL) had no effect
on CBT (upper panel) or MA (lower panel) in w-t and Kv4.22/2 mice. The circadian CBT profile of Kv4.22/2 mice was shifted by 1 h (two-way
repeated measures ANOVA followed by t-tests for each time point, * P,0.05). Data were pooled and averaged from 6 w-t (black) and 6 Kv4.22/2
(red) neurons. Data are plotted at 12 min intervals to emphasize the shift in circadian rhythm. The MA of Kv4.22/2 mice was not significantly
different (two-way repeated measures ANOVA followed by t-tests for each time point, P.0.2). B. Intra-MnPO injection of H3 antagonist thioperamide
(1 mM, 0.2 ml) delayed the CBT rise by 1 h in w-t (red) mice and had no effect in Kv4.22/2 mice (black). After thioperamide infusion the CBT profiles of
w-t and Kv4.22/2 mice were not different (two-way repeated measures ANOVA followed by t-tests for each time point, P.0.1).
doi:10.1371/journal.pone.0029134.g009
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0.2 mL). The toxin had no effect on the circadian rhythm of CBT in
Kv4.22/2 mice (Fig. 10A) but shifted the rising phase in CBT by
,1 h in w-t mice, the profile becoming similar to that of Kv4.22/2
mice (Fig. 10B). The toxin did not affect the MA of either w-t or
Kv4.22/2 mice (Fig. 10B) when injected intraMnPO.
Discussion
H3R activation decreases the firing rate of preoptic
GABAergic neurons by increasing IA
We have previously reported that histamine inhibits the firing
rate of preoptic GABAergic neurons by activating postsynaptic
H3Rs and subsequent decrease in the level of pERK1/2 [4]. In
this study we establish that activation of H3Rs decreases the
spontaneous firing rate also in acutely dissociated neurons and that
this effect is associated with a ,20% increase in IA. These findings
confirm the postsynaptic nature of histamine modulation of
preoptic GABAergic neurons. The percentage value of the IA
potentiation is similar with that reported by others in studies where
the current was found to be increased in response to neuromod-
ulators [20] or in response to direct inhibition of kinases [21], i.e.
in the range 10–30%. It is interesting to note that also in these
preparations IA is conducted by Kv4 subunits. This relatively
modest enhancement of IA resulted in robust reduction in firing
rate (,2.2% decrease in firing rate per 1% increase in current)
suggesting that this mechanism is a powerful mechanism for
controlling neuronal firing rates. This value is similar with that
reported for arcuate neurons (,2% decrease in firing rate per 1%
increase in current) [20] and comparable with that reported in
midbrain dopaminergic neurons (,1.8% decrease in firing rate
per 1% increase in current) [22].
Using dynamic clamp we also demonstrate that an enhance-
ment (by 20%) of IA is sufficient for decreasing the spontaneous
firing rate of the neuron by a similar extent to that induced by
H3R agonist. Previous studies have documented the role of IA in
spike frequency adaptation in response to depolarizing current
injections [23,24] and in regulating the rate of pacemaking activity
[20,25,26]. Our data further confirm the role of somatic IA in the
regulation of ‘‘pacemaker’’ firing activity by determining the
length of the depolarizing ramps preceding a spike [25,27]. It has
been shown, using siRNA knockdown, that Kv4 subunits are
necessary for generating subthreshold membrane potential
oscillations [28]. Here we prove that, conversely, increasing IA
by dynamic clamp results in such events occurring more
frequently.
Signaling pathway activated downstream of H3R
The H3 agonist-induced IA enhancement was mimicked by
decreasing the pERK1/2 level pharmacologically. Incubation with
the MEK-1 inhibitor also occluded additional effects of the agonist
confirming the central role played by ERK1/2 in this signaling
mechanism. We have also established that the Kv4.2 subunit, a
known ERK1/2 substrate [19,29] is required for H3 agonist-
induced augmentation of IA. This finding was surprising since also
the Kv4.1 and Kv4.3 subunits present ERK consensus sequences
Figure 10. Intra-MnPO injection of PaTx1 shifts the CBT circadian profile in w-t mice. A. CBT (upper panel) and MA (lower panel) responses
to intra-MnPO injection of PaTx1 (800 nM, 0.2 mL) (black) and aCSF (0.2 mL) (red) injections in Kv4.22/2 mice B. CBT (upper panel) and MA (lower
panel) responses to intra-MnPO injection of PaTx1 (800 nM, 0.2 mL) (black) and aCSF (0.2 mL) (red) injections in w-t mice. The toxin induced a ,1h
delay in the CBT rise associated with the active phase (two-way repeated measures ANOVA followed by t-tests for each time point, * P,0.05) and did
not affect motor activity (two-way repeated measures ANOVA followed by t-tests for each time point, P.0.3). A–B. The line graphs represent
averages6S.D. through the 24 h recording period. Experiments were carried out in parallel in 2 groups of 6 and Kv4.22/2 and w-t mice, respectively.
doi:10.1371/journal.pone.0029134.g010
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suggest a specific interaction of the Kv4.2 subunit with the H3/
pERK1/2 pathway.
Electrical remodeling of preoptic Kv4.22/2 neurons
The IA and the action potential characteristics were not
changed in Kv4.22/2 neurons, in spite of the fact that Kv4.2
subunits are highly expressed in w-t preoptic GABAergic neurons.
We found that Kv4.22/2 neurons presented a threefold increase
in the expression of the Kv4.1 subunit. This was unexpected since,
in contrast to Kv4.2 and Kv4.3, the Kv4.1 subunit is expressed
only at very low levels in preoptic neurons (and generally in the
brain). Another surprising finding was that while IA density was
little changed (14% smaller) in Kv4.22/2 neurons, the IDR
density was 81% higher than that of w-t neurons. Interestingly, a
similar upregulation of IDR was noticed also in Kv4.22/2 cortical
neurons [30], however, the role played by the upregulated IDR in
Kv4.22/2 neurons remains to be determined.
Role of preoptic histamine signaling in thermoregulation
Preoptic GABAergic neurons that express H3Rs contribute to
the inhibitory tone sent to neurons in the DMH and/or rRPA that
control thermogenesis (reviewed in [3]). Thus, in the presence of
H3 agonist a decrease in the frequency of their tonic firing results
in diminished inhibition of downstream thermoregulatory neurons
and increased thermogenesis. Although Kv4.22/2 mice were
able to develop full size hyperthermia when challenged with EP1/
3 agonist (intra-MnPO), they developed much smaller responses
than the w-t mice in response to intra-MnPO infusion of H3
agonist. In the presence of the Kv4 specific toxin PaTx1 the H3
agonist was without effect. Together with results in vitro discussed
above (with the caveat that those have been obtained in younger
animals) our findings indicate a central role of the Kv4.2 subunit in
the H3R signaling pathway in preoptic GABAergic neurons.
Since the hypothalamic concentration of histamine displays a
circadian rhythm [31] and increases during arousal [32,33] we
questioned the role of H3R signaling in this rhythm. We found
that intraMnPO infusion of thioperamide delayed the rise in CBT
associated with the active phase by ,1 h, strongly suggesting a
role of histamine acting at H3Rs. Interestingly, Kv4.22/2 mice
presented a similar shift in their circadian CBT profile in
agreement with a possible disruption of H3R signaling. These
results indicate for the first time a role of histamine signaling in
MnPO neurons for the control of the circadian profile in CBT.
However, we should note that thioperamide did not block the
increase in CBT associated with the active phase, indicating that
multiple mechanisms, possibly sequential, exist for the control of
this rhythm. Neither the H3 agonist nor the H3 antagonist
(administerd intra-MnPO) changed the motor activity of w-t or
Kv4.22/2 mice, confirming that histamine does not influence the
MA circadian rhythm as previously reported [34]. While CBT and
MA circadian rhythms are tightly coupled in normal conditions,
they are regulated by distinct anatomical substrates [35,36] and/or
signaling mechanisms [37]. Our results indicate that histamine
acting at H3Rs in preoptic GABAergic neurons provides a
mechanism of selective regulation of the circadian rhythm of CBT
at the beginning of the active phase.
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